动态
| 商品名 | 通用名 | 类别 | 生产商 | 上市年份 | 进入中国 |
|
Zaltrap
|
Aflibercept
|
2012 | |||
|
Bosulif
|
Bosutinib
|
2012 | |||
|
Cometriq
|
Cabozantinib
|
2012 | |||
|
Kyprolis
|
Carfilzomib
|
2012 | |||
|
Synribo
|
Mepesuccinate
|
2012 | |||
|
Poteligeo
|
Mogamulizumab
|
2012 | |||
|
Synribo
|
Omacetaxine Mepesuccinate
|
2012 | |||
|
Perjeta
|
Pertuzumab
|
2012 | |||
|
Pixuvri
|
Pixantrone Maleate
|
2012 | |||
|
Iclusig
|
Ponatinib
|
2012 | |||
|
Neutroval
|
Tbo-Filgrastim
|
2012 | |||
|
Marqibo
|
Vincristine Sulfate
|
2012 | |||
|
Erivedge
|
Vismodegib
|
2012 | |||
|
Forxiga
|
Dapagliflozin
|
2012 | |||
|
Tresiba
|
Insulin Degludec
|
2012 | |||
|
Signifor
|
Pasireotide
|
2012 | |||
|
Tenelia
|
Teneligliptin
|
2012 | |||
|
Tudorza Pressair
|
Aclidinium Bromide
|
2012 | |||
|
Glybera
|
Alipogene Tiparvovec
|
2012 | |||
|
Azilva
|
Azilsartan
|
2012 |
客服中心
客户案例
QQ客服
新浪微博
